
WSJ Opinion: Hits and Misses of the Week
Journal Editorial Report: The week’s best and worst from Kim Strassel, Kyle Peterson, Allysia Finley and Dan Henninger. Image: Chip Somodevilla/AFP via Getty Images …read more […]
Journal Editorial Report: The week’s best and worst from Kim Strassel, Kyle Peterson, Allysia Finley and Dan Henninger. Image: Chip Somodevilla/AFP via Getty Images …read more […]
Journal Editorial Report: Paul Gigot interviews Gen. Jack Keane on confronting Iran. Image: Vahid Reza Alaei/AFP via Getty Images …read more […]
Journal Editorial Report: Did the Democrats persuade undecided voters? Image: Chandan Khanna/AFP via Getty Images …read more […]
Caterpillar Inc. (NYSE:CAT) Q2 2020 Earnings Summary Jim Umpleby, Chairman & CEO “…The second quarter brought unprecedented challenges for our customers, dealers, employees and suppliers. We thank those in healthcare as well […]
Nikola Corporation (NASDAQ:NKLA) Q2 2020 Earnings Summary Mark Russell, CEO “…This is really exciting, Nikola’s first conference call as a public company. Going public through a business combination with VectoIQ was a critical […]
United Parcel Service, Inc. (NYSE:UPS) Q2 2020 Earnings Call Summary Carol Tomé, CEO “…I’m honored to be hosting my first UPS earnings call. Before I begin, I would like to thank David […]
Health Catalyst, Inc. (NASDAQ:HCAT) Q2 2020 Earnings Summary Dan Burton, CEO “To start, I’m happy to report that our total revenue for Q2 2020 was $43.3 million. This represents an outperformance relative […]
1Life Healthcare, Inc. (NASDAQ:ONEM) Q2 2020 Earnings Summary Amir Dan Rubin, CEO “…Today, we are pleased to report second quarter 2020 results at or above the high-end of our guidance across […]
iRhythm Technologies, Inc. (NASDAQ:IRTC) Q2 2020 Earnings Highlights Kevin King – President, CEO & Director “As we entered the second quarter, we faced many uncertainties related to the impact of COVID-19 and that would have […]
Pfizer Inc. and BioNTech SE disclosed “positive” data from an early trial of their BNT162b2 mRNA-based vaccine candidate against SARS-CoV2 and confirmed that they were on track to seek regulatory review as early as October.The news drove BioNTech (BNTX) shares up 10% on Friday, while Pfizer rose less than 1% at the close of day.Pfizer (PFE) and BioNTech shared additional Phase 1 safety and immunogenicity data from their ongoing US study of the BNT162 mRNA-based vaccine program against Covid-19.The newly released data shows key safety and immunogenicity data from the US Phase 1 trial for the BNT162b2 vaccine candidate, which …read more […]
Rates on 30-year loans are as low as 1.999%. Here are four tips for getting a good deal. …read more […]
Americans pay various types of taxes and discuss taxes in routine conversations. But how many people really know what basic terms and concepts mean? …read more […]
2020 will be remembered as the year of the biotech sector. Amid the ongoing pandemic, biotech stocks have taken center stage, with the names developing COVID-19 solutions being catapulted to remarkable highs. But, after posting such jaw-dropping gains, where do these stocks go from here? Morgan Stanley’s Chief U.S. Equity Strategist Mike Wilson says the story could get even better. Doubling down on his optimistic stance, he argues stimulus packages that support consumer demand as well as cost-cutting measures could be catalysts that spur strong showings in 2021. “We think that a return of topline growth and a material reduction …read more […]
Copyright 1997-2019 Wall Street Reporter / Octagon Media Corp.